Limiting Transactivator Amounts Contribute to Transgene Mosaicism in Tet-On All-in-One Systems

Area of Science:

• Molecular Biology
• Gene Therapy
• Biotechnology

Background:

• MicroRNAs are vital for cell function and hold therapeutic potential.
• Genetically engineering cells to express microRNAs requires controlled expression for safety and efficacy.
• Inducible gene expression systems, like the Tet-system, offer precise control over microRNA delivery.

Purpose of the Study:

• To investigate the causes of heterogeneous and unstable transgene expression in Tet-On all-in-one systems.
• To identify factors influencing the reliability of single-vector inducible gene expression for microRNA delivery.
• To establish methods for improving the stability and homogeneity of Tet-On system performance.

Main Methods:

• Utilized a reporter cell system to analyze transgene expression patterns.
• Correlated expression heterogeneity with levels of reverse tetracycline transactivator (rtTA).
• Employed targeted integration into a genomic safe harbor locus to enhance rtTA expression.

Main Results:

• Expression heterogeneity in Tet-On all-in-one systems primarily correlated with rtTA expression levels.
• Targeted integration of an rtTA expression cassette into a safe harbor locus restored silenced transcription units.
• Homogenous and stable rtTA expression was identified as critical for robust system performance.

Conclusions:

• Stable and homogenous rtTA expression is essential for reliable Tet-On all-in-one gene delivery systems.
• Addressing rtTA expression variability is key to optimizing Tet-On systems for research and therapeutic applications.
• Genomic safe harbor integration offers a strategy to improve the consistency of inducible gene expression.